
Lupin Limited has informed the Exchange regarding a press release dated January 06, 2021, titled "Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated January 06, 2021, titled "Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin